Walking a Thin “Wire”: The Attitudes and Principles of Harm Reduction Niladri Das, MD UPMC St. Margaret Family Medicine Residency Daniel Dejoseph,MD Drexel.

Slides:



Advertisements
Similar presentations
Amanda Barczyk, M.S.W. 1 & Valarie Garza 2 The University of Texas at Austin School of Social Work 1 Texas Health Institute 2.
Advertisements

Harm Reduction for Young People: Why A Youth Network? Diane Riley, PhD Canadian Foundation for Drug Policy, Youth Network for Harm Reduction & University.
Children and young people, injecting and HIV Under-18 and overlooked Young People and Injecting Drug Use: Overcoming barriers to HIV Prevention and Harmonizing.
Out of Sight, Out of Time: Injection Drug Users, Hepatitis C, and HIV Policy Daniel Raymond Hepatitis C Policy Analyst Harm Reduction Coalition
A call for prioritizing health and harm reduction in reforming drug policies Drug policy special session AIDS 2014 Melbourne July Dr Alex.
2 emcdda.europa.eu European drug report package A comprehensive analysis on the drugs problem in Europe.
Bringing Opioid Substitution Treatment to scale Dr. M. Suresh Kumar Inter-country Consultation on Preventing HIV among IDUs Scaling Up: From Evidence to.
Advocacy 1. What is Advocacy? ● Organized effort to influence policy change/decision making ● Action directed at changing approach of an individual/institution/group.
Delay from Testing HIV Positive until First HIV Care for Drug Users: Adverse Consequences and Possible Solutions Barbara J Turner MD, MSEd* John Fleishman.
Models of Harm Reduction
+ Opioid Substitution Therapy for Injecting Drug Users: Scale versus Quality WORKSHOP “OST in Developing Countries: A Primer” Atul Ambekar, Alok Agrawal.
Steven Shoptaw, PhD UCLA Department of Family Medicine Center for Behavioral and Addiction Medicine A DRAFT PACKAGE OF INTERVENTIONS.
Amethyst, Inc. Amethyst exists to nurture and sustain healthy women and families. We have been providing gender specific and trauma informed alcohol, tobacco.
Social Work Framework for Outreach Work Presentation 7.
Peterborough Drug Strategy
Municipal Drug Policy Legislation, institutions and programs Assoc. Prof. Hristo Bozov, MD, PhD Deputy-Mayor of Municipality of Varna Chairman of Municipal.
Harm Reduction Implementing Harm Reduction Strategies in Your Health Center.
Harm Reduction.
Overview of Harm Reduction and Sterile Syringe Access Anna Benyo Syringe Access Policy Coordinator Harm Reduction Coalition New Jersey Syringe Access Informational.
HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Signe ROTBERGA UNODC, Baltic States 5 November.
Recommendations on the Management of Opioid Overdose Ruth Birgin.
Medication Assisted Therapy for Opioid Addiction: Methadone and Buprenorphine Andrew J. Saxon, M.D. Veterans Affairs Puget Sound Health Care System and.
Overview of Drug Control in Foreign Countries. Drug Control in EU A. Policy Trends ■ Decriminalisation of possession of small amount of drugs for personal.
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, MA Deputy Director 2/23/20151.
To the Rescue: Naloxone Rescue and other Harm Reduction Strategies for Opioid Overdose Patricia McGuire, MD Collaborative Family Healthcare Association.
Quaboag Hills Community Coalition Substance Use Task Force October 20, 2014 Overview of the Strategic Prevention Framework (SPF) “Road Map” What are Evidence-Based.
Lydia H. Guterman Consultant, Open Society Institute September 25, 2008 Sofia, Bulgaria Many thanks to the Harm Reduction Coalition for partial content.
Naloxone nasal spray in Norway Thomas Clausen Professor (Dr. med) 5. November 2015.
Social and medical care of intravenous drug users in the Central Bohemian Region Czech Republic PhDr. Pavla Doležalová regional anti-drug coordinator.
Harm Reduction Team Maureen Woods Team Leader. Service Delivery Aims Develop harm reduction initiatives in partnership with other agencies to reduce the.
MODULE 2 Effective drug policy What needs to change?
What is it? What causes it? What can we do about it?
BEST PRACTICE PORTAL BEST PRACTICE PORTAL project presentation to the Scientific Committee Ferri et al Lisbon, 16th July 2010.
J. Aaron Johnson, PhD 1 and J. Paul Seale, MD 2 1 Institute of Public and Preventive Health and Department of Psychology, Georgia Regents University, Augusta,
THE 6 TH NATIONAL SCIENTIFIC CONFERENCE ON HIV/AIDS State of the art and new perspectives in drug addiction treatment Dr L Michel, MD, PhD Inserm U1178.
Overdose Prevention Pilot Project Cross Systems Collaboration. Naloxone Distribution In cooperation with LA Community Health Project June 4, 2014, VCBH,
Non-Medical Staff Knowledge, Beliefs and Practices about HIV and Hepatitis for Injection Drug Users Rowe, KA 1, Tesoriero, JM 1, Heavner, KK 1, Rothman,
Harm reduction evidence: Eastern Europe and Central Asia Raminta Stuikyte Central and Eastern European Harm Reduction Network.
Denis G. Patterson, DO ECHO Project April 20, 2016 CDC Guidelines for Prescribing Opioids for Chronic Pain.
Health Research Title Student Name Teacher & Class Period Date.
MODULE 3 Harm reduction advocacy
State Targeted Response to Opioid Crisis
Charlie Howsare, MD MPH Pa. Viral Hepatitis Prevention Coordinator
Riga city Council Welfare department HIV prevention
Medication-Assisted Therapy at Coleman Profession Services
Needle and syringe exchange and working with injecting drug users
Department of Psychiatry Section of Population Behavioral Health
Integrating Smoking Cessation with Substance Abuse Treatment
McLean Hospital Division of Alcohol and Drug Abuse
Addressing Drug Use Together Through a Health Based Approach:
Addiction: A Love/Hate Relationship
Community Action on Harm Reduction (CAHR) Programme
Impact of Academic Detailing in the Chicagoland Region: A Pilot Study
Steve Alsum The Grand Rapids Red Project
Decriminalisation Policy and the role of the CDT
Jonathan Mermin, MD, MPH RADM, USPHS
Social Awareness Programme
A State Targeted Response to the Opioid Crisis:
Substance abuse reveiw
Head of Research centre
Alyona Mazhnaya, Jill Owczarzak
Pain Management and Substance Use Disorders: JCPP Strategic Session
Embedding SBIRT (Screening, Brief Intervention and Referral to Treatment) into Health Professional Trainees’ Curriculum Hartman, Cheri W. 1; Hartman, David.
Samaritan Behavioral Health Inc. (SBHI)
Rationale –Evidence Base
Alcohol, Other Drugs, and Health: Current Evidence July-August, 2018
No conflicts of interest
Strategic Initiatives to Address Opioid Overdose & Addiction
Human Dignity and Harm Reduction
What is it? What causes it? What can we do about it?
Presentation transcript:

Walking a Thin “Wire”: The Attitudes and Principles of Harm Reduction Niladri Das, MD UPMC St. Margaret Family Medicine Residency Daniel Dejoseph,MD Drexel Family Medicine Residency

Objectives Identify principles of harm reduction Explore the learner’s response to substance abuse Discuss barriers to the treatment of addiction

The Wire The Origins of Hamsterdam

What is Harm Reduction? Defined by the WHO as: A concept aiming to prevent or reduce negative health consequences associated with certain behaviors What’s the connection with “The Wire”? “WPRO: Harm Reduction Among Injecting Drug Users” WPRO

Principles of Harm Reduction Pragmatism Humanistic Values Focus on Harms Balancing Costs and Benefits Priority of Immediate Goals Hunt, Neil. “A review of the evidence-base for harm reduction approaches to drug use” IHRA, = Are we going to Eliminate Drug Use? = Not approval but not moral judgement = Not the Use Itself = Evaluation = Goal Setting

Lancet 2010; 376: 1558–65

What are the substance abuse disorders you self identify as the most problematic in you practice?

Lancet 2010; 376: 1558–65

JAMA Mar 10;291(10):

Back to “The Wire” Areas of Most/Least Harm

Does Harm Reduction Work? Depends on your goals. What are some examples of harm reduction that you think work? Portugal: New diagnoses of HIV 1430 in 2000 to 352 in 2008 BMJ 2010;341:c4554 Opioid Substitution Therapy: Metanalysis showing reduction of injection, sharing, and risk. Harm reduction among injecting drug users — evidence of effectiveness, EMCDDA, Lisbon, April 2010 Peer Naloxone Distribution: Multiple studies, 15months Boston; 385 participants=74 Reversals Am J Public Health May; 99(5): 788–791. Syringe Services Programs: Overwhelming evidence for HIV reduction; SAMHSA Wet Houses

Back to “The Wire” Difficult Patient Encounter Think about the difficult patient encounters that you have had. What made them difficult?

Consider Again Your Practice Are you using any harm reduction principles or programs now? Are there any ideas that you would consider implementing in your practice?

The END